Craig M. Crews
@craigmcrews.bsky.social
📤 4114
📥 5689
📝 57
pinned post!
It's an honor to share this year's Passano Award with Ray Deshaies, Ph.D. for the development of PROTACs, a new therapeutic modality that targets proteins for degradation via co-opting the cellular protein recycling machinery.
about 1 year ago
1
55
2
reposted by
Craig M. Crews
Nico Dantuma
about 17 hours ago
How mitochondria hinder destruction of mutant proteins that cause Parkinson's and Huntington's disease. Our latest study published in Nature Communications.
www.nature.com/articles/s41...
loading . . .
Mitochondria serve as a holdout compartment for aggregation-prone proteins hindering efficient degradation - Nature Communications
Accumulation of aggregation-prone proteins is linked to neurodegenerative diseases. Here, the authors show that mitochondrial association hinders cells to efficiently clear these toxic proteins. Preve...
https://www.nature.com/articles/s41467-026-72783-0
0
6
3
reposted by
Craig M. Crews
Clausen Lab
about 17 hours ago
Open Postdoc Position - Giant E3 ligases: mysterious mechanisms & non‑protein substrates. Interested? Join us to uncover how these molecular giants tag lipids, RNAs, sugars beyond proteins, on organelles and pathogens, to defend the cell. Details & Application here
www.imp.ac.at/career/open-...
1
16
23
reposted by
Craig M. Crews
Shicheng Guo
about 16 hours ago
New TPD tech, ERADECs, efficiently degrades transmembrane proteins by hijacking ERAD, opening new avenues for drug discovery in challenging targets! PMID:41861782, Cell 2026,
@Cell
https://www.cell.com/cell/fulltext/S0092-8674(26)00105-4
#Medsky
#Pharmsky
#RNA
#ASHG
#ESHG
🧪
loading . . .
https://www.cell.com/cell/fulltext/S0092-8674(26)00105-4
No description available
https://www.cell.com/cell/fulltext/S0092-8674(26)00105-4
0
4
1
reposted by
Craig M. Crews
Shicheng Guo
4 days ago
CLEO4-88 acts as a molecular glue, inhibiting ACAA1 by binding GID4 in CTLH E3 ligase; key in targeted protein degradation! 🌟 PMID:41957281, Nat Chem Biol 2026, @nchembio
https://doi.org/10.1038/s41589-026-02183-4
#Medsky
#Pharmsky
#RNA
#ASHG
#ESHG
🧪
loading . . .
The molecular glue CLEO4-88 inhibits the ACAA1 thiolase by induced binding to GID4 | Nature Chemical Biology
Molecular glues promote protein–protein interactions by enhancing the surface complementarity between proteins. Those that recruit an E3 ubiquitin ligase to a target can elicit ubiquitination and subsequent destruction of the target protein—a mechanism that underpins the field of targeted protein degradation (TPD). Here we explored whether small-molecule binders to the CTLH E3 ligase subunit GID4 could act as molecular glues. We discovered that CLEO4-88 functions as a molecular glue (EC50 = 12.5 nM) to promote the interaction of GID4 with the peroxisomal thiolase ACAA1 in vitro and in cellulo. An atomic structure of the ternary complex revealed an allosteric mechanism whereby CLEO4-88 binds solely to GID4 and induces a conformational change conducive to binding ACAA1. Biochemical analysis demonstrated that, while ACAA1 cannot be recruited by GID4 to a CTLH holoenzyme for ubiquitination, ternary complex formation inhibits ACAA1 thiolase activity, thus demonstrating potential utility bey
https://doi.org/10.1038/s41589-026-02183-4
0
6
2
reposted by
Craig M. Crews
4 days ago
onlinelibrary.wiley.com/doi/10.1002/...
"Dr. Pollard reflects on key discoveries that shaped the actin field and on the role of quantitative thinking in biology."
loading . . .
Foundational Discoveries in Actin Regulation: An Interview With Tom Pollard
Dr. Thomas D. Pollard's work transformed cytoskeleton research into a quantitative, mechanistic science. Over five decades, he established core principles of actin dynamics, including filament polari...
https://onlinelibrary.wiley.com/doi/10.1002/cm.70146
0
7
6
rdcu.be/fi3WP
loading . . .
The atypical E3 ligase HOIL-1 safeguards the ribosome during cellular stress
Nature Cell Biology - Douglas et al. study the E3 ligase HOIL-1, mutated in patients with a type of myopathy. Mutant HOIL-1 influences the sensitivity to disulfidptosis initiated by...
https://rdcu.be/fi3WP
6 days ago
0
9
0
reposted by
Craig M. Crews
Kermit Murray
8 days ago
Targeted degradation of USP7 in solid cancer cells reveals distinct effects of deubiquitinase degraders and inhibitors
#nature
#MassSpecRSS
loading . . .
Targeted degradation of USP7 in solid cancer cells reveals distinct effects of deubiquitinase degraders and inhibitors - Nature Communications
DUBs regulate key cellular processes, but selective tools are scarce. Here, the authors developed PROTACs for the DUB USP7, comparing degraders with inhibitors. The study provides a valuable toolbox for studying DUB functions and underscores the power of PROTACs in revealing context-specific biology.
http://dlvr.it/TSXJSz
0
4
1
reposted by
Craig M. Crews
Ahmad Jomaa
8 days ago
Excited to share our work uncovering SNOR, a ribosome-associated factor that promotes translation restart after dormancy published in Nature!! This was, as usual, a wonderful collaborative effort between our group and the Mattei Lab
@simonemattei.bsky.social
@embl.org
www.nature.com/articles/s41...
loading . . .
4
140
63
Z-TAC enables custom and combinatorial degradation of cell surface proteins
loading . . .
https://www.biorxiv.org/content/10.64898/2026.04.03.716357v2
8 days ago
1
7
2
reposted by
Craig M. Crews
Max Planck Institute of Biochemistry
9 days ago
New work from the Schulman Dept. shows mechanisms of metabolite-regulated E3 ligase activity. Read more about it: “Cysteine availability tunes ubiquitin signaling via inverse stability of LRRC58 E3 ligase and its substrate CDO1” in Nature Communications.
www.nature.com/articles/s41...
0
18
6
reposted by
Craig M. Crews
PastelBio
9 days ago
Tracking Protein Misfolding and Oligomerization: A Temperature-Controlled Ion Mobility-Mass Spectrometry Approach
pubs.acs.org/doi/10....
---
#proteomics
#prot-paper
0
5
3
reposted by
Craig M. Crews
Alexis Verger 🧬🧫🧪
9 days ago
[Review] The past, present and future of de novo protein design
www.nature.com/articles/s41...
loading . . .
The past, present and future of de novo protein design - Nature
A Review of de novo protein design highlights key methodological advances and achievements, current challenges and future applications.
https://www.nature.com/articles/s41586-026-10328-7
0
12
3
reposted by
Craig M. Crews
Marvin Tanenbaum
9 days ago
For 40 years the 8-nt ‘Kozak Sequence’ was thought to mark sites of translation initiation. In a new study, we revise this model by identifying an ~80-nt sequence—the extended Translation Initiation Sequence (eTIS)— that guides ribosomes to correct start sites. 🧵
www.biorxiv.org/content/10.6...
loading . . .
https://www.biorxiv.org/content/10.64898/2026.05.12.723742v1
3
172
77
reposted by
Craig M. Crews
Julia Lazzari-Dean
10 days ago
We invented “triplet tumbling microscopy” (TTM) to track protein-protein interactions in living cells! Tag your protein with GFP and see it interact with *untagged* binding partners
www.biorxiv.org/content/10.6...
4
163
61
reposted by
Craig M. Crews
Doudna Lab
10 days ago
New pre-print 📣 “Undruggable” cancer mutations remain very hard to target with current modalities. What if we could instead sense mutant transcripts and convert that recognition into selective cell killing? Check out this work led by postdoc Jingkun Zeng:
www.biorxiv.org/content/10.6...
loading . . .
https://www.biorxiv.org/content/10.64898/2026.05.08.723607v1
1
37
17
reposted by
Craig M. Crews
Nikolai Slavov
10 days ago
Single-cell proteomics illuminated new mechanisms of mammalian development. We found that spatially polarized protein distributions and intracellular protein gradients emerge during the earliest stages of mammalian embryogenesis and bias subsequent cell fate decisions.
www.cell.com/cell/fulltex...
1
21
7
reposted by
Craig M. Crews
Institut Pasteur | 130 years of biomedical research
10 days ago
🦠💡 Bacteria have millions of secret weapons against viruses! Researchers used AI to uncover millions of new bacterial proteins likely involved in antiviral defense — suggesting immunity genes make up ~1.5% of the genome, 3× more than thought. 🔗
www.pasteur.fr/en/research-...
@audeber.bsky.social
loading . . .
Bacteria Have Millions of Secret Weapons Against Viruses
Millions of new proteins with predicted roles in defence against viruses have been identified in bacteria. It was thought that around 0.5% of the average bacterial genome had some involvement in immun...
https://www.pasteur.fr/en/research-journal/news/bacteria-have-millions-secret-weapons-against-viruses
0
21
5
reposted by
Craig M. Crews
Kevin A. Scott
10 days ago
alphafold uses covariation in evolutionary sequence alignments to predict structural contacts. evolution-guided pharmacology uses covariation networks to identify functional hotspots — evolutionarily constrained regions that may be pharmacologically targetable. more soon.
1
8
3
reposted by
Craig M. Crews
Kevin Mitchell
13 days ago
TranscriptFormer: A generative cell atlas across 1.5 billion years of evolution
www.science.org/doi/10.1126/...
- this looks cool! 👀
loading . . .
TranscriptFormer: A generative cell atlas across 1.5 billion years of evolution
Single-cell transcriptomics is revolutionizing our understanding of cellular diversity, yet comparing transcriptional programs across the tree of life remains challenging. We developed TranscriptForme...
https://www.science.org/doi/10.1126/science.aec8514
1
26
14
reposted by
Craig M. Crews
Shicheng Guo
11 days ago
Cancer cells reveal Src on their surface via exocytosis, opening doors for new treatments targeting this classic oncogene. PMID:41818382, Science 2026,
@ScienceMagazine
https://doi.org/10.1126/science.aef9956
#Medsky
#Pharmsky
#RNA
#ASHG
#ESHG
🧪
loading . . .
https://doi.org/10.1126/science.aef9956
No description available
https://doi.org/10.1126/science.aef9956
0
2
1
reposted by
Craig M. Crews
Covalent Modifiers
12 days ago
Covalent Inhibitors of Monoacylglycerol Lipase Induce Conformational Changes and Proteasomal Degradation
https://covalentmodifiers.blogspot.com/2026/05/covalent-inhibitors-of-monoacylglycerol.html
0
0
1
reposted by
Craig M. Crews
Christine Mayr
14 days ago
If you want to know what 3′UTRs with long conserved sequence stretches do, check out our BioRxiv preprint
doi.org/10.64898/202...
. They form functional intermolecular 3′UTR-3′UTR interactions that enable co-folding of proteins to rapidly induce transcriptional programs.
5
133
59
reposted by
Craig M. Crews
Yale Cancer Center
13 days ago
A Yale-led innovation based on research by
@craigmcrews.bsky.social
, has received FDA approval for
#breastcancer
treatment.
#Vepdegestrant
marks a major milestone for PROTAC technology and targeted protein degradation in oncology.
news.yale.edu/2026/05/07/y...
loading . . .
Yale-led technology receives FDA approval for breast cancer treatment
The biotech company Arvinas was originally founded based on pioneering research from Yale chemist Craig Crews into PROTAC protein degraders.
https://news.yale.edu/2026/05/07/yale-led-technology-receives-fda-approval-breast-cancer-treatment
0
12
4
First PROTAC gains FDA approval, bolstering targeted protein degradation and induced proximity ambitions
www.nature.com/articles/d41...
loading . . .
First PROTAC gains FDA approval, bolstering targeted protein degradation and induced proximity ambitions
Discover the world’s best science and medicine | Nature.com
https://www.nature.com/articles/d41573-026-00078-6
13 days ago
0
130
38
reposted by
Craig M. Crews
Nature Reviews Immunology
16 days ago
"True scientific progress depends on a culture that protects dissent, especially in emotionally or politically charged areas." as discussed by Akiko Iwasaki
@virusesimmunity.bsky.social
in a recent World View article
loading . . .
Freedom of scientific inquiry: reclaiming space for controversy
Nature Reviews Immunology - No matter how small the possibility, or how inconvenient the topic, scientists must maintain the humility to acknowledge that we could be wrong. Our inability to remain...
https://rdcu.be/fhbbP
0
9
6
reposted by
Craig M. Crews
Devin Schweppe
16 days ago
With a few days since it's been out
@keribackus.bsky.social
@oligopain.bsky.social
and I wanted to highlight a few of our favorite aspects of POCA for photocatalytic proximity labeling of DNA, RNA or proteins. (1) POCA builds on standard in situ hybridization and immunofluorescence workflows.
add a skeleton here at some point
1
16
9
reposted by
Craig M. Crews
Nature Cancer
17 days ago
🔥Online now, a Review on EMT as driver of tumor cell plasticity By
@nietoangela.bsky.social
and
@ruljcz.bsky.social
Part of our Series on Tumor Heterogeneity and Plasticity:
nature.com/collections/...
nature.com/articles/s43...
loading . . .
Epithelial-to-mesenchymal transition as a central driver of tumor cell plasticity - Nature Cancer
Jimenez-Castaño and Nieto review the latest research on cellular plasticity associated with epithelial–mesenchymal transition (EMT) states in cancer cells, highlighting the contributions of EMT to tum...
https://nature.com/articles/s43018-026-01154-x?utm_source=bluesky&utm_medium=social&utm_campaign=natcancer
0
6
2
reposted by
Craig M. Crews
Shicheng Guo
17 days ago
Lactate fuels cancer through ERK lactylation by GCN5, activating ERK phosphorylation. This feedback loop drives malignancy! PMID:41530530, Nat Chem Biol 2026, @nchembio
https://doi.org/10.1038/s41589-025-02107-8
#Medsky
#Pharmsky
#RNA
#ASHG
#ESHG
🧪
loading . . .
GCN5–ERK lactylation–phosphorylation loop amplifies lactate-driven cancer progression | Nature Chemical Biology
The Warburg effect leads to increased lactate production and promotes cancer progression but the underlying mechanisms remain unclear. Here, we found that lactate activates the MAPK pathway through ERK lactylation, which promotes cancer progression. We identified GCN5 as the lactyltransferase responsible for ERK lactylation. Activated ERK phosphorylates GCN5, increasing its lactyltransferase activity toward ERK and establishing a positive feedback loop that amplifies lactate-mediated cancer progression. We provide evidence that lactylation of ERK at residue K231 weakens its interaction with MEK, thereby promoting ERK dimerization and activation. We developed a cell-penetrating peptide that specifically inhibits ERK lactylation. This peptide impairs tumor growth in KRAS-mutant cancer models. Taken together, our findings reveal a molecular mechanism by which lactate accelerates cancer progression through the ERK–GCN5 lactylation–phosphorylation cascade and suggest a strategy to disrupt E
https://doi.org/10.1038/s41589-025-02107-8
1
8
3
reposted by
Craig M. Crews
MRC Laboratory of Molecular Biology
17 days ago
The hidden rules behind mRNA transport. A collaborative study between
@simonbullock11.bsky.social
&
@carter-lab.bsky.social
’s groups has found a structural code that explains how cells selectively transport mRNAs. Read more:
mrclmb.ac.uk/news-events/...
#LMBNews
@cellbiol-mrclmb.bsky.social
🧪
0
35
19
reposted by
Craig M. Crews
Keri Backus
19 days ago
Super excited to launch POCAxOMAP with
@dschweppe.bsky.social
and
@oligopain.bsky.social
and led by Eli Biletch, Conor Herlihy and Lidan Li. If you’ve ever wanted to do proximity labeling on DNA, RNA, or protein without genetic engineering, look no further.
www.biorxiv.org/content/10.6...
1
80
37
reposted by
Craig M. Crews
Jonathan Rosenblum
24 days ago
The compounds are 26Da different. Erasca added two methyls and a proton. Would be pretty impressive if this is different IP on a compound that's over 800Da. It's also pretty impressive that Erasca's dose is 40mg and RevMed's in 300mg. Science!
1
5
3
reposted by
Craig M. Crews
Keri Backus
24 days ago
Super excited that our SEE-CITE photoaffinity labeling method is now out in
@natchem.nature.com
rdcu.be/ffBSC
. Here we introduce a custom silyl ether cleavable linker between a diazirine photocrosslinker handle and molecules of interest to streamline site-of-labeling analysis for PAL chemoproteomics
1
43
16
reposted by
Craig M. Crews
Igor Ulitsky
21 days ago
🆕 review with
@jpunfried.bsky.social
out in Nature SMB. Direct roles of lncRNAs in transcriptional activation. What do we understand about how lncRNAs lure Pol2 and set the stage for RNA production, and what do we still miss?
www.nature.com/articles/s41...
loading . . .
Direct roles of long non-coding RNAs in transcription activation - Nature Structural & Molecular Biology
This Review discusses how long noncoding RNAs (lncRNAs) control transcription activation by RNA polymerase II, including how they are produced at active enhancers or chromatin-domain boundaries and ac...
https://www.nature.com/articles/s41594-026-01795-7
0
47
17
reposted by
Craig M. Crews
Jonathan Mannion
20 days ago
The FDA approval of vepdegestrant for ESR1-mutant ER+/HER2− advanced breast cancer marks an important milestone for PROTACs! Beyond its importance for patients, this is a landmark validation of targeted protein degradation as a therapeutic modality 👏🏻
www.fda.gov/drugs/resour...
loading . . .
FDA approves vepdegestrant for ER-positive, HER2-negative, ESR1-mutate
FDA approves vepdegestrant for ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer
https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-vepdegestrant-er-positive-her2-negative-esr1-mutated-advanced-or-metastatic-breast
1
12
6
reposted by
Craig M. Crews
Keith Hornberger
24 days ago
Discovery of SD-965 as a Potent, Selective, and Efficacious STAT3 PROTAC Degrader
loading . . .
Discovery of SD-965 as a Potent, Selective, and Efficacious STAT3 PROTAC Degrader
Signal transducer and activator of transcription 3 (STAT3) is a promising therapeutic target for human cancers and other human diseases. Herein, we report on the design, synthesis, and evaluation of n...
https://pubs.acs.org/doi/10.1021/acs.jmedchem.5c03767
0
6
2
reposted by
Craig M. Crews
Todd Douglas
22 days ago
Our paper is now out in
@natcellbio.nature.com
!
@craigmcrews.bsky.social
www.nature.com/articles/s41...
We identify a new regulator of the quality control system that protects one of nature's most important molecular machines: the ribosome. QC failure → unmitigated metabolic stress & cell death.
loading . . .
The atypical E3 ligase HOIL-1 safeguards the ribosome during cellular stress - Nature Cell Biology
Douglas et al. study the E3 ligase HOIL-1, mutated in patients with a type of myopathy. Mutant HOIL-1 influences the sensitivity to disulfidptosis initiated by ZAKα–ATF4 in glucose starvation and inte...
https://www.nature.com/articles/s41556-026-01936-6
2
39
22
reposted by
Craig M. Crews
Jan Żylicz
25 days ago
Check it out if you are interested in how metabolism regulates epigenetics and cell fate. Should also be relevant to some of the cancer folk.
add a skeleton here at some point
0
11
5
reposted by
Craig M. Crews
Immunity
24 days ago
Online now: Krüppel-like factor 2 programs early exhausted T cell states and restrains antiviral immunity
loading . . .
Krüppel-like factor 2 programs early exhausted T cell states and restrains antiviral immunity
Geng et al. identify KLF2 as a central regulator of CX3CR1+ effector-like exhausted CD8+ T cells during chronic infection. KLF2 is uniquely expressed and both necessary and sufficient for this state. Disrupting the KLF2-dependent program enhances viral control without inducing overt immunopathology.
http://dlvr.it/TSFXBy
0
3
1
reposted by
Craig M. Crews
Nick Leigh
25 days ago
🐸Do salamanders need adaptive immunity to regenerate limbs and tails? 🐸 Nope! 🚨Check out back-to-back pre-prints from PhD student in our lab Chimezie (
tinyurl.com/42wst3bh
) and from our collaborators the Max Yun lab (
tinyurl.com/b92rzwzr
)
1
16
8
reposted by
Craig M. Crews
Julian Nüchel
24 days ago
💥 New publication from the Demetriades and Nüchel groups– final version now online in EMBO reports! This Tour de force wouldn’t have worked out without the amazing support from our collaborators and core facilities!
loading . . .
GRASP55 maintains lysosome function by controlling sorting of lysosomal enzymes at the Golgi - EMBO Reports
Lysosomes are multifunctional organelles that play important roles in cellular recycling, signaling, and homeostasis, relying on precise trafficking and activation of lysosomal enzymes. While the Golg...
https://link.springer.com/article/10.1038/s44319-026-00773-w
1
19
10
reposted by
Craig M. Crews
Adam Gilbert
24 days ago
Identification of an STING inhibitor targeting the allosteric transmembrane domains: Cell Chemical Biology
www.cell.com/cell-chemica...
loading . . .
Identification of an STING inhibitor targeting the allosteric transmembrane domains
Chen et al. introduce Y-320, a potent allosteric STING inhibitor that uniquely binds to the transmembrane domain instead of the canonical binding pocket, thereby blocking STING activation and traffick...
https://www.cell.com/cell-chemical-biology/fulltext/S2451-9456%2826%2900110-8
0
8
3
reposted by
Craig M. Crews
Lisa Jarvis
28 days ago
RFK Jr. is trying to downplay his hostility to vaccines. Don’t believe the hype. My latest, for
@opinion.bloomberg.com
, on his measles blame game during his testimony before lawmakers: (🎁)
loading . . .
RFK Jr. Can’t Hide From Measles’ Comeback
Across marathon hearings before lawmakers over the past week, Health Secretary Robert F. Kennedy Jr. was repeatedly challenged over his response to the ongoing measles outbreak — and he repeatedly ref...
https://www.bloomberg.com/opinion/articles/2026-04-24/vaccine-critic-rfk-jr-can-t-hide-from-his-measles-record?accessToken=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzb3VyY2UiOiJTdWJzY3JpYmVyR2lmdGVkQXJ0aWNsZSIsImlhdCI6MTc3NzAzNTY2OCwiZXhwIjoxNzc3NjQwNDY4LCJhcnRpY2xlSWQiOiJURFpVSUlLSVAzT0YwMCIsImJjb25uZWN0SWQiOiJBQkE5NzNFNjA3NkQ0NjMyODJFMDAyN0QyM0JDNTg5MyJ9.SF4m5H_9j3_4p24HtPv-6nZkm07ZrBYk_yMahqXfh8Q
1
29
16
reposted by
Craig M. Crews
Komander Lab
28 days ago
Check out our latest paper on the ubiquitination of glycogen in cells and tissues! Congratulations to Marco Jochem (
@marcojochem.bsky.social
) and Simon Cobbold for leading this study and to collaborators
@craigagoodman1.bsky.social
,
@pgregorevic.bsky.social
, Kai Hofmann and Thomas Hermanns.
add a skeleton here at some point
0
36
20
reposted by
Craig M. Crews
PastelBio
29 days ago
Peptide-centric local stability assay (PELSA) for sensitive identification of ligand-targeting proteins and binding sites at proteome scale
www.nature.com/artic...
---
#proteomics
#prot-paper
0
0
1
reposted by
Craig M. Crews
Marco Jochem
29 days ago
Interested in non-proteinaceous ubiquitination, induced proximity or glycogen? Then you should have a look at our newest article, “Ubiquitination of glycogen and metabolites in cells and tissues”, just published in Nature:
www.nature.com/articles/s41...
5
52
35
reposted by
Craig M. Crews
PastelBio
29 days ago
The Ubiquitin Script: writing protein fates in chains
portlandpress.com/es...
---
#proteomics
#prot-paper
1
3
3
reposted by
Craig M. Crews
Center of Medical Biotechnology
about 1 month ago
Next up: Katerina Naydenova, Group Leader at the Max Planck Institute of Molecular Physiology, will present "Molecular mechanisms of
#ubiquitin
ligases with activity towards non-protein substrates". 📅 22 April 2026 ⏰ 12:30 📍 S05 V01 E69 ➡️
www.mpi-dortmund.mpg.de/forschungsgr...
loading . . .
Katerina Naydenova
Katerina Naydenova
https://www.mpi-dortmund.mpg.de/forschungsgrupen/naydennova
0
9
4
reposted by
Craig M. Crews
The Friedman Brain Institute
about 1 month ago
MARK YOUR CALENDARS | On May 5th, 3pm, in Hatch Auditorium & hosted by
@paulkennyphd.bsky.social
, Dr. Ming-Ming Zhou & Dr. Mone Zaidi, Yale University's Dr
@craigmcrews.bsky.social
will give a Special Seminar concerning one of the most exciting areas in drug discovery research today. Please join us!
1
4
2
reposted by
Craig M. Crews
Spirochrome
about 1 month ago
What a probe! Congratulations
@cepourroy.bsky.social
! We're happy to share that we re working hard on making CenSpark probes available to the centriole aficionados in the coming weeks!
add a skeleton here at some point
1
13
4
Load more
feeds!
log in